Idan Shalev

Dr. Idan Shalev

Department of Biobehavioral Health, Pennsylvania State, University, University Park, PA 16801, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2023 in Ageing Research Reviews
Verified
Journal Article
Closed access
QYQiaofeng Ye
Qiaofeng Ye
AAAbner T. Apsley
Abner T. Apsley
LELaura Etzel
Laura Etzel
WHWaylon J. Hastings
Waylon J. Hastings
JKJohn T. Kozlosky
John T. Kozlosky
ISIdan Shalev
Idan Shalev

18 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LELaura Etzel
Laura Etzel
WHWaylon J. Hastings
Waylon J. Hastings
MHMolly A. Hall
Molly A. Hall
CHChristine M. Heim
Christine M. Heim
MMMichael J. Meaney
Michael J. Meaney
ISIdan Shalev
Idan Shalev
New insights into mechanisms linking obesity to poor health outcomes suggest a role for cellular aging pathways, casting obesity as a disease of accelerated biological aging. Although obesity has been linked to accelerated epigenetic aging in middle-aged adults, the impact during childhood remains unclear. We tested the association between body mass index (BMI) and accelerated epigenetic aging in a cohort of high-risk children. Participants were children (N = 273, aged 8 to 14 years, 82% investigated for maltreatment) recruited to the Child Health Study, an ongoing prospective study of youth investigated for maltreatment and a comparison youth. BMI was measured as a continuous variable. Accelerated epigenetic aging of blood leukocytes was defined as the age-adjusted residuals of several established epigenetic aging clocks (Horvath, Hannum, GrimAge, PhenoAge) along with a newer algorithm, the DunedinPoAm, developed to quantify the pace-of-aging. Hypotheses were tested with generalized linear models. Higher age-and sex- adjusted z-scored BMI was significantly correlated with household income, blood cell counts, and three of the accelerated epigenetic aging measures: GrimAge (r = 0.31, P < .0001), PhenoAge (r = 0.24, P < .0001), and DunedinPoAm (r = 0.38, P < .0001). In fully adjusted models, GrimAge (β = 0.07; P = .0009) and DunedinPoAm (β = 0.0017; P < .0001) remained significantly associated with higher age- and sex-adjusted z-scored BMI. Maltreatment-status was not associated with accelerated epigenetic aging. In a high-risk cohort of children, higher BMI predicted epigenetic aging as assessed by two epigenetic aging clocks. These results suggest the association between obesity and accelerated epigenetic aging begins in early life, with implications for future morbidity and mortality risk.

1 May 2016 in Medical Hypotheses
Verified
Journal Article
Closed access
ISIdan Shalev
Idan Shalev
JBJay Belsky
Jay Belsky

1 June 2011 in Hormones and Behavior
Verified
Journal Article
Closed access
ISIdan Shalev
Idan Shalev
SISalomon Israel
Salomon Israel
FUFlorina Uzefovsky
Florina Uzefovsky
IGInga Gritsenko
Inga Gritsenko
MKMarsha Kaitz
Marsha Kaitz
RERichard Ebstein
Richard Ebstein

1 November 2014 in Pediatrics
Verified
Journal Article
Open access
PDF file
ISIdan Shalev
Idan Shalev
ACAvshalom Caspi
Avshalom Caspi
AAAntony Ambler
Antony Ambler
DBDaniel W. Belsky
Daniel W. Belsky
SCSimon Chapple
Simon Chapple
TMTerrie E. Moffitt
Terrie E. Moffitt
BACKGROUND: Perinatal complications predict increased risk for morbidity and early mortality. Evidence of perinatal programming of adult mortality raises the question of what mechanisms embed this long-term effect. We tested a hypothesis related to the theory of developmental origins of health and disease: that perinatal complications assessed at birth predict indicators of accelerated aging by midlife. METHODS: Perinatal complications, including both maternal and neonatal complications, were assessed in the Dunedin Multidisciplinary Health and Development Study cohort (N = 1037), a 38-year, prospective longitudinal study of a representative birth cohort. Two aging indicators were assessed at age 38 years, objectively by leukocyte telomere length (TL) and subjectively by perceived facial age. RESULTS: Perinatal complications predicted both leukocyte TL (β = −0.101; 95% confidence interval, −0.169 to −0.033; P = .004) and perceived age (β = 0.097; 95% confidence interval, 0.029 to 0.165; P = .005) by midlife. We repeated analyses with controls for measures of family history and social risk that could predispose to perinatal complications and accelerated aging, and for measures of poor health taken in between birth and the age-38 follow-up. These covariates attenuated, but did not fully explain the associations observed between perinatal complications and aging indicators. CONCLUSIONS: Our findings provide support for early-life developmental programming by linking newborns’ perinatal complications to accelerated aging at midlife. We observed indications of accelerated aging “inside,” as measured by leukocyte TL, an indicator of cellular aging, and “outside,” as measured by perceived age, an indicator of declining tissue integrity. A better understanding of mechanisms underlying perinatal programming of adult aging is needed.

9 January 2025 in Aging Cell
Verified
Journal Article
Open access
AAAbner T. Apsley
Abner T. Apsley
QYQiaofeng Ye
Qiaofeng Ye
ACAvshalom Caspi
Avshalom Caspi
CCChristopher Chiaro
Christopher Chiaro
LELaura Etzel
Laura Etzel
ISIdan Shalev
Idan Shalev
Epigenetic clocks are a common group of tools used to measure biological aging—the progressive deterioration of cells, tissues, and organs. Epigenetic clocks have been trained almost exclusively using blood‐based tissues, but there is growing interest in estimating epigenetic age using less‐invasive oral‐based tissues (i.e., buccal or saliva) in both research and commercial settings. However, differentiated cell types across body tissues exhibit unique DNA methylation landscapes and age‐related alterations to the DNA methylome. Applying epigenetic clocks derived from blood‐based tissues to estimate epigenetic age of oral‐based tissues may introduce biases. We tested the within‐person comparability of common epigenetic clocks across five tissue types: buccal epithelial, saliva, dry blood spots, buffy coat (i.e., leukocytes), and peripheral blood mononuclear cells. We tested 284 distinct tissue samples from 83 individuals aged 9–70 years. Overall, there were significant within‐person differences in epigenetic clock estimates from oral‐based versus blood‐based tissues, with average differences of almost 30 years observed in some age clocks. In addition, most epigenetic clock estimates of blood‐based tissues exhibited low correlation with estimates from oral‐based tissues despite controlling for cellular proportions and other technical factors. Notably, the Skin and Blood clock exhibited the greatest concordance across all tissue types, indicating its unique ability to estimate chronological age in oral‐ and blood‐based tissues. Our findings indicate that application of blood‐derived epigenetic clocks in oral‐based tissues may not yield comparable estimates of epigenetic age, highlighting the need for careful consideration of tissue type when estimating epigenetic age.